Читать книгу Il Morbo Di Parkinson: Le Fasi Finali - Dr. Juan Moisés De La Serna - Страница 9

Bibliografia

American Psychiatric Association. DSM-5, Manual diagnóstico y estadístico de los trastornos mentales. Panamericana; 2018.

Basu R, Rosenman RE. Altruism and Informal Care for Dementia. Int J Soc Sci Stud 2013;2:70–82. https://doi.org/10.11114/ijsss.v2i1.185.

Cockrell JR, Folstein MF. Mini-mental state examination. Princ Pract Geriatr Psychiatry 2002:140–1.

Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308–14. https://doi.org/10.1212/wnl.44.12.2308.

Cummings JL. The Neuropsychiatric Inventory-Questionnaire: Background and Administration. n.d.

Dick JP, Guiloff RJ, Stewart A, Blackstock J, Bielawska C, Paul EA, et al. Mini-mental state examination in neurological patients. J Neurol Neurosurg \& Psychiatry 1984; 47:496–9.

EuroQol - a new facility for the measurement of health-related quality of life. Health Policy (New York) 1990; 16:199–208. https://doi.org/10.1016/0168-8510(90)90421-9.

Fi M, Dw B. Functional evaluation: the Barthel index. Md State Med J 1965; 14:5.

Gill DJ, Freshman A, Blender JA, Ravina B. The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson’s disease. Mov Disord Off J Mov Disord Soc 2008; 23:1043–6.

Guy W. Clinical global impression. Assess Man Psychopharmacol 1976:217–22.

Hoehn MM, Yahr MD. Parkinsonism: Onset, progression, and mortality. Neurology 1967;17:427–42. https://doi.org/10.1212/WNL.17.5.427.

ICD-11 - Mortality and Morbidity Statistics n.d. https://icd.who.int/browse11/l-m/en (accessed December 14, 2020).

Jenkinson C, Fitzpatrick RAY, Peto VI V, Greenhall R, Hyman N. The Parkinson’s Disease Questionnaire (PDQ-39): development and validation of a Parkinson’s disease summary index score. Age Ageing 1997;26:353–7.

Lawson R, Yarnall A, Johnston F, Duncan G, Khoo T, Collerton D, et al. Cognitive impairment in Parkinson’s disease: impact on quality of life of carers. Int J Geriatr Psychiatry 2017;32:1362–70. https://doi.org/10.1002/gps.4623.

Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Williams-Gray CH, et al. Cognitive decline and quality of life in incident Parkinsons disease: The role of attention. Park Relat Disord 2016;27:47–53. https://doi.org/10.1016/j.parkreldis.2016.04.009.

Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012;27:349–56. https://doi.org/10.1002/mds.24893.

Martínez-Martín P, Rodríguez-Blázquez C, Forjaz MJ, de Pedro J, Aguilar M, Álvarez Saúco M, et al. The clinical impression of severity index for Parkinsons disease: International validation study. Mov Disord 2009;24:211–7. https://doi.org/10.1002/mds.22320.

Martínez-Martín P, Rojo-Abuin JM, Rodríguez-Violante M, Serrano-Dueñas M, Garretto N, Martínez-Castrillo JC, et al. Analysis of four scales for global severity evaluation in Parkinsons disease. Npj Park Dis 2016;2:16007. https://doi.org/10.1038/npjparkd.2016.7.

Nicholl CG, Lynch S, Kelly CA, White L, Simpson PM, Wesnes KA, et al. The cognitive drug research computerized assessment system in the evaluation of early dementia-is speed of the essence? Int J Geriatr Psychiatry 1995;10:199–206.

on Rating Scales for Parkinson’s Disease MDSTF. The unified Parkinson’s disease rating scale (UPDRS): status and recommendations. Mov Disord 2003;18:738–50.

Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, Rabbitt P. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dement Geriatr Cogn Disord 1994;5:266–81.

Schwab RS. Projection technique for evaluating surgery in Parkinsons disease. Third Symp. Park. Dis., 1969, p. 152–7.

Viktrup L, Hayes RP, Wang P, Shen W. Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. BMC Urol 2012;12. https://doi.org/10.1186/1471-2490-12-30.

Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 1982;17:37–49. https://doi.org/10.1016/0022-3956(82)90033-4.

Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361–70. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x.